Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab-Reference-Cited by-同舟云学术

Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab

Published:2024-05-04 Issue: Volume: Page:
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:

Author:

Umeda Masataka¹²^ORCID,Kojima Kanako¹,Michitsuji Toru¹,Tsuji Yoshika¹,Shimizu Toshimasa¹,Fukui Shoichi¹,Sumiyoshi Remi¹,Koga Tomohiro¹,Kawashiri Shin-ya¹,Naoki Iwamoto¹,Iagawa Takashi¹,Tamai Mami¹,Origuchi Tomoki¹,Furuyama Masako³,Tsuboi Masahiko⁴,Matsuoka Naoki⁴,Okada Akitomo⁵,Aramaki Toshiyuki⁶,Kawakami Atsushi¹²

Affiliation:

1. Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan

2. Research Unit for Preventive and Clinical Medicine, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan

3. Department of Rheumatology, Nagasaki Kita Hospital , Nagasaki, Japan

4. Nagasaki Medical Hospital of Rheumatology , Nagasaki, Japan

5. Department of Rheumatology, National Hospital Organization Nagasaki Medical Center , Omura, Japan

6. Department of Rheumatology, Sasebo Chuo Hospital , Sasebo, Japan

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/mr/advance-article-pdf/doi/10.1093/mr/roae038/57709220/roae038.pdf

Reference5 articles.

1. Autoimmunity and organ damage in systemic lupus erythematosus;Tsokos;Nat Immunol,2020

2. New biologics and targeted therapies in systemic lupus: from new molecular targets to new indications. A systematic review;Felten;Joint Bone Spine,2023

3. Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks;Neupane;Lupus Sci Med,2023

4. Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus;Bruce;J Comp Eff Res,2022

5. Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases;Ota;Ann Rheum Dis,2023